Park Place Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60 Hold
10
﹤0.01% 846
2025
Q4
$72 Hold
10
﹤0.01% 782
2025
Q3
$107 Hold
10
﹤0.01% 784
2025
Q2
$101 Hold
10
﹤0.01% 807
2025
Q1
$149 Sell
10
-60
-86% -$923 ﹤0.01% 818
2024
Q4
$1.04K Sell
70
-100
-59% -$1.63K ﹤0.01% 782
2024
Q3
$3.25K Buy
170
+100
+143% +$2.07K ﹤0.01% 727
2024
Q2
$1.45K Hold
70
﹤0.01% 812
2024
Q1
$1.32K Hold
70
﹤0.01% 869
2023
Q4
$1.01K Sell
70
-9
-11% -$122 ﹤0.01% 832
2023
Q3
$1.37K Buy
79
+9
+13% +$188 ﹤0.01% 961
2023
Q2
$1.46K Hold
70
﹤0.01% 973
2023
Q1
$1.65K Hold
70
﹤0.01% 964
2022
Q4
$2K Buy
+70
New +$1.79K ﹤0.01% 961

Other funds holding OGN

Park Place Capital's OGN Position: Q1 2026 in Review

Park Place Capital held its Organon & Co (OGN) position steady in Q1 2026 at 10 shares worth $60. The position accounts for ﹤0.01% of the portfolio, ranked #846.

Park Place Capital first reported a position in OGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.25K in Q3 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Park Place Capital held 10 shares of Organon & Co worth $60 as of Q1 2026.
  • Park Place Capital left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Park Place Capital's portfolio in Q1 2026, its #846 holding.
  • Park Place Capital first reported a position in Organon & Co in Q4 2022 and has held it in 14 quarters since.
  • Park Place Capital's Organon & Co position peaked at $3.25K in Q3 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.